Biotech

All Articles

Rivus' stage 2 obesity-related heart failure test attacks endpoint

.Rivus Pharmaceuticals has plumped up the leads of its fat-busting, muscle-sparing medicine prospect...

Ovid stops preclinical job, IV course after soticlestat neglect

.Ovid Rehab already showed final month that it was actually trimming its head count as the business ...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston ma Port

.Eli Lilly has actually opened up a $700 thousand R&ampD facility in the Boston ma Seaport, enhancin...

Boundless Bio produces 'moderate' discharges 5 months after $100M IPO

.Simply five months after securing a $100 thousand IPO, Boundless Biography is already laying off so...

Halda's $126M will certainly evolve 'secure as well as get rid of' lump drugs

.The initial stages of oncology R&ampD may not be except interesting brand new modalities, as well a...

Lykos 'remorses' not disclosing research transgressions with publisher

.Psychopharmacology has actually pulled three posts concerning midstage medical test records determi...

Analysts dig into Avidity's DMD win, exposing distinctions in data

.Avidity Biosciences impressed financiers along with period 1/2 records in Duchenne muscular dystrop...

Actinogen's cortisol blocker neglects period 2 anxiety research

.Actinogen Medical's cortisol blocker has skipped the primary endpoint of a period 2 study in depres...

Bivictrix chooses going exclusive only means to take ADC in to center

.Antibody-drug conjugates (ADCs) have actually been at the facility of lots of a billion-dollar biob...

TPG leadings up funds to $580M for financial investments all over life scientific researches

.Property supervisor TPG, which has sustained biotechs including Sionna Therapeutics and also Santa ...